Phase 3 Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers: A Randomized, Placebo-controlled, Double-blind, Parallel-group, Multi-center Study
Phase of Trial: Phase III
Latest Information Update: 10 Aug 2018
At a glance
- Drugs Adipose stem cell therapy Anterogen (Primary)
- Indications Diabetic foot ulcer
- Focus Therapeutic Use
- Sponsors Anterogen
- 02 Aug 2018 Planned End Date changed from 1 Dec 2019 to 30 Sep 2019.
- 02 Aug 2018 Planned primary completion date changed from 1 Dec 2019 to 30 Jun 2019.
- 02 Aug 2018 Status changed from not yet recruiting to recruiting.